Figure 2From: Low RBM3 protein expression correlates with tumour progression and poor prognosis in malignant melanoma: An analysis of 215 cases from the Malmö Diet and Cancer StudyPrognostic value of RBM3 expression in primary melanoma. Tumours with high (strong intensity) RBM3 expression had a significantly improved (A) recurrence free survival and (B) overall survival compared to tumours with low RBM3 expression (negative to moderate intensity).Back to article page